Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Mar 25:12:627565.
doi: 10.3389/fimmu.2021.627565. eCollection 2021.

Editorial: Skin Autoimmunity

Khalaf Kridin  1   2 , Katja Bieber  1 , Christian D Sadik  3 , Michael P Schön  4   5 , Gang Wang  6 , Karin Loser  7 , Ralf J Ludwig  1
Affiliations
Editorial

Editorial: Skin Autoimmunity

Khalaf Kridin et al. Front Immunol. .
No abstract available

Keywords: alopecia aerata (AA); autoimmunity; pemphigoid; pemphigus; psoriasis; skin.

PubMed Disclaimer

Conflict of interest statement

MS has received honoraria from AbbVie, Biogen, Almirall, Leo, Novartis, UCB, Janssen, Leo. RL has received honoraria and/or research grants from the following companies: Admirx, Almirall, Amryth, ArgenX, Biotest, Biogen, Euroimmun, Incyte, Immungenetics, Lilly, Novartis, UCB Pharma, Topadur, True North Therapeutics and Tx Cell. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Skin Autoimmunity

References

    1. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky’s postulates revisited). Immunol Today (1993) 14:426–30. 10.1016/0167-5699(93)90244-F - DOI - PubMed
    1. Sondermann W, Herz S, Sody E, Körber A. Dermatological complications of therapy with biologics in inflammatory autoimmune diseases. J Dtsch Dermatol Ges (2019) 17:1029–37. 10.1111/ddg.13964 - DOI - PubMed
    1. Kähler KC, Hassel JC, Heinzerling L, Loquai C, Thoms KM, Ugurel S, et al. Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma - an update. J Dtsch Dermatol Ges (2020) 18:582–609. 10.1111/ddg.14128 - DOI - PubMed
    1. Schmidt E, Zillikens D. Pemphigoid diseases. Lancet (2013) 381:320–32. 10.1016/S0140-6736(12)61140-4 - DOI - PubMed
    1. Schmidt E, Kasperkiewicz M, Joly J. Pemphigus. Lancet (2019) 394:882–94. 10.1016/S0140-6736(19)31778-7 - DOI - PubMed

Publication types